Single tooth replacement with dental implants in the aesthetic zone. A randomized clinical trial of different implant designs and different times of restoration.

ISRCTN ISRCTN37243042
DOI https://doi.org/10.1186/ISRCTN37243042
Secondary identifying numbers NTR422
Submission date
27/01/2006
Registration date
27/01/2006
Last edited
19/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr L. Hartog, den
Scientific

University Medical Center Groningen
Hanzeplein 1
Groningen
9713 GZ
Netherlands

Email L.den.hartog@kchir.umcg.nl

Study information

Study designRandomised open label active controlled parallel group
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesThe purpose of this study is to evaluate and compare the aesthetic definitive outcome of:
1. Three different implant designs
2. Two different times of restoration, namely immediate and conventional restoration
The null hypothesis is that there are no differences in the definitive aesthetic outcome of different implant designs or times of restoration.
Ethics approval(s)Received from local medical ethics committee
Health condition(s) or problem(s) studiedDental implant, single-tooth
InterventionPatients are randomly assigned to the following study groups:
Group I: a dental implant of the ‘NobelReplace Tapered’ system is inserted in the anterior zone of the maxilla. After an osseointegration period of three months a temporary restoration is made.
Group IIA: a dental implant of the ‘NobelReplace Groovy’ system is inserted in the anterior zone of the maxilla. Within 24 hours a temporary restoration is placed.
Group IIB: a dental implant of the ‘NobelReplace Groovy' system is inserted in the anterior zone of the maxilla and a temporary restoration is made after three months
Group III: a dental implant of the ‘NobelPerfect’ system is inserted in the anterior zone of the maxilla and a temporary restoration is made after three months
Intervention typeOther
Primary outcome measureAesthetic Index according to Meijer et al. 2005
Secondary outcome measures1. Implant survival
2. Marginal bone resorption
3. Papil-index
4. Recession
5. Patient satisfaction
Overall study start date01/09/2004
Completion date01/09/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants120
Key inclusion criteria1. The patient is 18 years or older
2. The missing or lost tooth is an incisor (central or lateral), a canine or a first bicuspid in the maxilla. The adjacent teeth are natural teeth.
3. Sufficient healthy and vital bone to insert a dental implant with a minimum length of 10 mm and at least 3.5 mm in diameter. In case of insufficient bone volume, a bone augmentation procedure will be performed with autologue bone. After three months of healing, the dental implant will then be inserted.
4. The implant site must be free from infection
5. Adequate oral hygiene (modified plaque index and modified sulcus bleeding index <1)
6. Sufficient mesio-distal, bucco-lingual, and interocclusal space for placement of an anatomic restoration
7. If necessary, the temporary restoration can be designed free from occlusal contact
8. The patient is capable of understanding and giving informed consent
Key exclusion criteria1. Medical and general contraindications for the surgical procedures
2. Presence of an active and uncontrolled periodontal disease
3. Presence of pathologic microflora
4. Bruxism
5. Site of implant placement is an extraction wound younger than three months
6. Smoking (patients who stop smoking six weeks before the operation can be included)
7. A history of local radiotherapy to the head and neck region
Date of first enrolment01/09/2004
Date of final enrolment01/09/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Medical Center Groningen
Groningen
9713 GZ
Netherlands

Sponsor information

University Medical Centre Groningen (UMCG) (Netherlands)
Not defined

Hanzeplein 1
Groningen
9713 GZ
Netherlands

ROR logo "ROR" https://ror.org/03cv38k47

Funders

Funder type

Industry

Nobel Biocare (Switzerland)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan